Clinical Trials on Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma
Total 4355 results
-
Acrotech Biopharma Inc.RecruitingPeripheral T Cell LymphomaUnited States
-
Zhao WeiliNot yet recruiting
-
Ruijin HospitalRenJi Hospital; West China Hospital; Shandong Provincial Hospital; Tianjin Medical... and other collaboratorsRecruitingPeripheral T Cell LymphomaChina
-
Second Affiliated Hospital, School of Medicine,...Ningbo No. 1 Hospital; Jinhua Central Hospital; Huizhou Municipal Central HospitalRecruiting
-
Henan Cancer HospitalRecruitingPeripheral T-Cell LymphomaChina
-
Peking UniversityPeking University Cancer Hospital & InstituteNot yet recruitingNK/T Cell LymphomaChina
-
iCell Gene TherapeuticsPeking University Shenzhen Hospital; iCAR Bio Therapeutics Ltd.RecruitingRefractory T-Cell Lymphoma | T Cell Lymphoma in RelapseChina
-
Genor Biopharma Co., Ltd.RecruitingPeripheral T Cell LymphomaChina
-
Antengene CorporationActive, not recruitingPeripheral T-cell Lymphoma | NK/T-cell LymphomaChina
-
Innate PharmaCompletedPeripheral T Cell LymphomaKorea, Republic of, United States
-
University of Colorado, DenverBristol-Myers SquibbActive, not recruitingPeripheral T Cell LymphomaUnited States
-
Conjupro Biotherapeutics, Inc.CSPC ZhongQi Pharmaceutical Technology Co., Ltd.Withdrawn
-
Nanjing Sanhome Pharmaceutical, Co., Ltd.UnknownPeripheral T Cell Lymphoma
-
Zhejiang Cancer HospitalUnknownPeripheral T Cell LymphomaChina
-
Eisai Co., Ltd.CompletedPeripheral T-Cell LymphomaJapan
-
The University of Hong KongUnknown
-
The First Affiliated Hospital of Soochow UniversityUnknown
-
H. Lee Moffitt Cancer Center and Research InstituteSeagen Inc.TerminatedPilot Study of Brentuximab Vedotin in Relapsed/Refractory Peripheral T-Cell Lymphoma Expressing CD30Peripheral T-Cell LymphomaUnited States
-
Nanfang Hospital of Southern Medical UniversityUnknownPeripheral T Cell LymphomaChina
-
Kyowa Hakko Kirin Pharma, Inc.CompletedPeripheral T-Cell LymphomaFrance, United Kingdom, Netherlands, Denmark, Italy, Spain
-
Samsung Medical CenterCompleted
-
University Hospital, GrenobleFrench Innovative Leukemia OrganisationCompletedPeripheral T Cell LymphomaFrance
-
Mahidol UniversityBayerTerminatedPeripheral T-Cell LymphomaThailand
-
University of PennsylvaniaCompletedNon-Hodgkins Lymphoma (NHL) Patients, With CD19+B Cell LymphomasUnited States
-
Chonbuk National University HospitalSamsung Medical Center; Pusan National University Hospital; Chonnam National... and other collaboratorsCompletedAngioimmunoblastic T-cell Lymphoma | Peripheral T-Cell Lymphoma, Not Otherwise Specified | Anaplastic Large Cell Lymphoma, ALK-negativeKorea, Republic of
-
The First Affiliated Hospital with Nanjing Medical...Not yet recruiting
-
Samsung Medical CenterCompletedExtranodal NK/T Cell LymphomaKorea, Republic of
-
National Cancer Institute (NCI)CompletedAnaplastic Large Cell Lymphoma, ALK-Positive | Ann Arbor Stage II Noncutaneous Childhood Anaplastic Large Cell Lymphoma | Ann Arbor Stage III Noncutaneous Childhood Anaplastic Large Cell Lymphoma | Ann Arbor Stage IV Noncutaneous Childhood Anaplastic Large Cell LymphomaUnited States
-
National Cancer Institute (NCI)TerminatedNodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Lymphoblastic Lymphoma | Recurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Mantle Cell Lymphoma | Recurrent Marginal Zone... and other conditionsUnited States
-
Ruijin HospitalNot yet recruitingNK-T-Cell Lymphoma, ExtranodalChina
-
Sichuan UniversityUnknown
-
The First Affiliated Hospital with Nanjing Medical...Not yet recruiting
-
Ruijin HospitalRecruiting
-
Won Seog KimRecruitingT Cell LymphomaKorea, Republic of
-
Washington University School of MedicineSecuraBioRecruitingT-Cell LymphomaUnited States
-
Yale UniversityCompletedT Cell LymphomaUnited States
-
Sun Yat-sen UniversityNot yet recruitingExtranodal NK/T-cell Lymphoma, Nasal TypeChina
-
ImmuneOncia Therapeutics Inc.Active, not recruitingA Study of IMC-001 in Subjects With Relapsed or Refractory Extranodal NK/T Cell Lymphoma, Nasal TypeExtranodal NK/T-cell Lymphoma, Nasal Type | Extranodal NK/T-cell LymphomaKorea, Republic of
-
Innovent Biologics (Suzhou) Co. Ltd.TerminatedExtranodal NK/T Cell Lymphoma, Nasal TypeChina
-
Ruijin HospitalActive, not recruitingExtranodal NK/T-cell Lymphoma, Nasal TypeChina
-
Sun Yat-sen UniversityEli Lilly and CompanyUnknownExtranodal NK/T-cell Lymphoma, Nasal TypeChina
-
Fudan UniversityUnknownExtranodal NK/T-cell Lymphoma, Nasal TypeChina
-
Eli Lilly and CompanyCompletedT-Cell Lymphoma | B-Cell LymphomaMexico, United States, Australia, Brazil, Peru
-
H. Lee Moffitt Cancer Center and Research InstituteKyowa Hakko Kirin Pharma, Inc.Recruiting
-
Cairo UniversityNot yet recruiting
-
Cairo UniversityUnknown
-
European Organisation for Research and Treatment...CompletedLymphomaGermany, Switzerland, Israel, United Kingdom, Austria, Italy
-
National Cancer Institute (NCI)UnknownLymphomaSouth Africa
-
University of WashingtonCompleted
-
Jiangsu HengRui Medicine Co., Ltd.RecruitingPeripheral T-cell LymphomaChina